
Lilac Diesel or Purps: terpinolene versus caryophyllene and an untraceable lineage
Both strains are available in Polish pharmacies from the same three manufacturers and fall within the same range of declarations, yet they are divided by the leading terpene and whether anything can be said about their origin.
How do these two strains really differ?
In terms of the leading terpene and origin, not potency. Both sources place terpinolene at the forefront of the Lilac Diesel profile, while caryophyllene leads for Purps. The breeder publicly provided the lineage for the first strain, but the second's lineage remains undetermined. The declared active substance content is the same on both sides, so this pair does not separate.
Agreement on the profile leader is stronger here than is often the case in this comparison. For Lilac Diesel, the base providing weights places terpinolene well ahead of the next position, and the service listing only the order names it first. For Purps, both sources consistently indicate caryophyllene, followed closely by nerolidol. The dispute between sources only begins lower down the list, and that is what constitutes the real content of this comparison.
The second difference lies in how consistently each has been described. The six medicinal entries for Lilac Diesel receive the same set of aroma descriptors: citrus, floral, and lavender, plus a fuel component. The four entries for Purps receive three different sets, sharing exactly one word: earthy. This is not a difference between the plants, but between the quality of the description.
The genetic class is even disputed for both names. For the first strain, sources alternate between hybrid and sativa, while for the second, they waver between indica-dominant hybrid and pure indica. Anyone looking to separate this pair by percentages or genetic labeling will find no distinction here or there.
What connects them?
Almost the entire set of names in the profile and the path to the medicinal shelf. Of the nine terpenes mentioned for this pair, seven are present on both sides. There is also a common group of producers and a range of declarations. The lineage graph does not connect these strains in any way, as one of them has no recorded parents.
The common core of the profile is larger than the leading terpene label suggests. On both sides stand bisabolol, humulene, caryophyllene, limonene, linalool, myrcene, and pinene. Each strain has exactly one unique name: terpinolene for Lilac Diesel, nerolidol for Purps. Thus, the entire difference in composition boils down to two positions on the list and to weights that one of the sources does not provide at all.
They are also connected by the way they reach the Polish pharmacy. Both are listed in the registration positions of S-LAB, Synoptis Pharma, and Tilray, and industry publications state that the first two entities maintain trade relations with the third. For the patient, this means that the manufacturer's name on the packaging does not have to indicate a different cultivation, and each of these strains is described separately in its dedicated entry about Lilac Diesel oraz we wpisie o Purps.
What does not connect them with anything verifiable is their origin. The parents of the first strain are recorded in the graph, while the parents of the second are not, so a common ancestor cannot be indicated or excluded. An empty field does not imply a negative answer here, and we treat it as a lack of knowledge, not as evidence of a lack of kinship.
Where does each of these strains come from?
One has a documented lineage from the breeder, the other is from nowhere, with the latter being a result of verification, not a gap in our work. Lilac Diesel has four recorded parents and a specified author of the cross. For Purps, the verification concluded with a determination that the origin of the medicinal entry cannot be established.
On the side of Lilac Diesel, the record is short and verifiable. Seed banks attribute this strain to an American breeding company and indicate four parental lines. The first two are silver lemon haze and forbidden fruit, while the next two are nyc cherry pie and citral glue. The name carries a fuel component, but none of the four parents have such a component, so the word in the name does not come from the lineage and says nothing about it.
On the side of Purps, the verification yielded the opposite result, which is worth stating directly. The name circulates in at least three different lines: a clone strain from Mendocino County, where the breeding base itself describes the second parent as unknown; its seed version released later by a Canadian company; and a separate purple family, for which the most frequently mentioned cross is purple urkle with big bud. Polish descriptions of the same medicinal entry sometimes refer to one version, sometimes to the other, and no document from the producer mentions the parents.
Therefore, the pedigree field here has an unknown value and is not a section to be filled in. Entering any of the circulating versions would create a false connection with strains that have documented pedigrees: in the same comparison stands Big Purple Dragon with a recorded parent purple urkle, and adopting the popular Polish version would make these two names close relatives without any basis.
How do the lists of terpenes provided by the two sources differ?
By a discrepancy that has a different direction on each side. For both strains, the sources differ in composition, but not in the same way: for Purps, one source simply provides a shorter version of the other’s list, while for Lilac Diesel, each lists something that the neighbor does not have at all.
For Purps, the direction is one-sided. The database describing four medicinal entries lists a complete set of eight names, while the service describing one entry lists four, and all four are included in that complete set. The shorter version lacks humulene, linalool, myrcene, and pinene, while it does not add any unique names. It is therefore a subset of the longer one, which fits well with the fact that it is backed by one side instead of four.
For Lilac Diesel, both lists extend beyond each other. The base with weights adds bisabolol, humulene, and limonene, which the other side does not mention, while the other side adds myrcene, absent in that taxonomy. Neither list contains the other, so it cannot be said that one is a shortened version of the other. The discrepancy can also occur within a single service: on the pages of this strain, the list of names and the weight table contradict each other, while for Purps, both places provide the same on each page.
We do not provide percentage shares with the names, and this pair shows why better than any general argument. For the first strain, the complete set of numbers repeats in each of the six entries and sums to 58 percent. For the second, the same database provides a sum of 99 percent once, and 89 percent another time, and this is for entries of the same cultivar. The denominator is therefore unknown, and additionally unstable within a single source.
How much active substance do the medicinal entries of both strains declare?
The same amount, and this number does not resolve anything here. The declared THC content encompasses the same range of 16.2-24.2% on both sides, as in both cases, the registered entries reaching the Polish shelf have two different nominal levels. Thus, the range describes the assortment, not the plant.
These are not the ranges of a single producer and do not result from the ten percent tolerance itself. The range arises from the declarations of several separate registered entries, some of which declare a lower nominal level, while others declare a higher one, and only each of them separately receives its own deviation from the declared value. One nominal number cannot yield the endpoints of 16.2-24.2%.
The distribution of levels on both sides is, however, different. The eight collected entries for Lilac Diesel are evenly divided, four for each level, with the base indicating availability marking only those with the higher level as present for sale. For Purps, the lower level is declared by one entry out of five collected, so the lower end of the range stands on a single registered entry, and its withdrawal would make the entire strain appear stronger, even though nothing would change within it.
Availability changes over time, as it is determined by individual batches and delivery dates, not by the cultivar description. What is available in pharmacies today is updated continuously. a compilation of available medical marijuana strains.
After what time do both strains start to take effect and how long does the effect last?
Identically, as the pace depends on the method of intake, not the name on the package. Neither of them has been the subject of a separate pharmacokinetic study, so the difference in the duration of action cannot be demonstrated in either direction between this pair. The following description pertains to the method of administration and applies to both names.
The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.
What is known about the effects of both strains, and what has not been demonstrated?
There is separate knowledge about two terpenes, nothing about the strains themselves. Terpinolene has two preclinical studies, caryophyllene has two others, and none of these four concerned dried flower or patients. Everything else circulating about the effects of this pair is patient reports or sales material.
| Pair page | Work | Year and journal | Identifier | Study model |
|---|---|---|---|---|
| Lilac Diesel (terpinolene) | Ito K, Ito M | 2013, Journal of Natural Medicines | PMID:23339024 | rodent (mouse, inhalation) |
| Lilac Diesel (terpinolene) | Okumura N, Yoshida H, Nishimura Y, Kitagishi Y, Matsuda S | 2012, Oncology Letters | PMID:22740904 | test tube (human cell line K562) |
| Purps (caryophyllene) | Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A | 2008, Proceedings of the National Academy of Sciences (PNAS) | PMID:18574142 | mouse (in vivo) and test tube (receptor binding, human cells) |
| Purps (caryophyllene) | Klauke AL, Racz I, Pradier B, Markert A, Zimmer AM, Gertsch J, Zimmer A | 2014, European Neuropsychopharmacology | PMID:24210682 | rodent (mouse) |
On the Lilac Diesel side, both studies are either animal-based or in vitro. Inhaled terpinolene exhibited a calming (sedative) effect in mice; the effect persisted even in mice with impaired olfaction, indicating that the action occurred after the compound was absorbed into the body through the nose, rather than solely through the perception of smell. The second study addresses a completely different question. Terpinolene reduced the level of AKT1 protein and inhibited the proliferation of human leukemia cells from the K562 line in culture; the study did not address pain, sleep, or anxiety.
No effects of terpinolene on pain, anxiety, or sleep were observed in humans or in any animal pain model; the available data only includes calming effects after inhalation in mice and its impact on the leukemia cell line in vitro.
On the Purps side, the material is different as it includes the mechanism and pain model. (E)-caryophyllene selectively bound to the CB2 receptor (Ki = 155 nM) and inhibited paw swelling induced by carrageenan in wild-type mice, but not in mice lacking the CB2 receptor (Cnr2-/-), indicating a CB2-dependent mechanism; the study did not include any anxiety tests. The second study went further into pain. Oral caryophyllene reduced the late inflammatory phase of pain in the formalin test in a CB2-dependent manner, with no effect on the early phase; in a neuropathic pain model, it alleviated thermal hyperalgesia and mechanical allodynia without developing tolerance with chronic administration.
Neither of the two studies tested caryophyllene on humans or in inhaled form from dried flower; both studies pertain to oral or systemic administration in mice in pain and inflammation models, not sleep or mood.
Both boundaries should be read separately for each side of the pair. A stronger material on one side does not transfer to the other, and above all, none of these results indicate what the dried flower given to the patient does, as in each of the four cases, a single compound was studied, not the plant.
What side effects have been reported for each of these two strains?
There are no reports attributed to either of these two names, as safety oversight is conducted by a registry according to the medicinal product batch, and the cultivar does not appear in such a record. The symptoms described below pertain to the entire group of hemp raw materials. A differing number of reports for the two names would not be evidence of a safety difference.
Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.
The only thing that can be said separately about this pair comes from commercial material: one of the strains is attributed with stimulating effects, while the other is relaxing. This is a sales label, not a clinical observation, and does not indicate which of them more frequently exhibits the symptoms mentioned above. Anyone noticing any of these symptoms should report them to their attending physician, as only they see the entire list of preparations being taken.
Frequently Asked Questions about Lilac Diesel and Purps
Which of these two strains has stronger dried flower?
Declarations on both sides cover the same range of active substance content, so based on the numbers from the registry, it is not possible to indicate a stronger one. The difference between two individual pharmacy items of the same strain can be greater than the difference between these two names.
Are Lilac Diesel and Purps related?
It is unknown and cannot be determined. The parents of Lilac Diesel are listed in the pedigree chart, while the parents of Purps are not, so a common ancestor cannot be identified or excluded.
Why do you not provide a pedigree for Purps?
Because the name circulates in several different breeding lines, and none of them can be confidently assigned to the position sold in Polish pharmacies. Listing any of the circulating versions would create a false kinship with strains that have documented pedigrees.
Since both strains have almost the same set of terpenes, why separate them?
Because the set of names is not the same as the profile. Both sources consistently place terpinolene at the forefront of the first strain and caryophyllene at the forefront of the second, and this difference is not shown by the ingredient list itself.
Are the percentage shares of terpenes provided online reliable?
Not enough to quote them. For the first of these strains, the numbers provided by the Polish database sum up to 58 percent, for the second once to 99 and once to 89 percent, so the denominator is unknown and variable even within a single source.
Is over-the-counter dried hemp the same product?
No, it is a different category: at the address the dried flower category there is hemp flower with cannabidiol, sold over the counter and with a concentration of psychoactive substances below the legal threshold, while both strains described here are pharmaceutical raw materials dispensed only by a doctor's prescription.
Dried hemp is a pharmaceutical raw material dispensed by a doctor's prescription in the Rpw category. The material is informational in nature and does not replace medical advice. The editorial text was prepared by redakcja ubucha.pl.







